Mustang Bio Inc reports results for the quarter ended in June - Earnings Summary

Mustang Bio

15/08/2023 20:10

* Mustang Bio Inc  MBIO.OQ  reported a quarterly adjusted
loss of
$2.00​​ per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for a loss of
$1.81 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Mustang Bio Inc's reported EPS for the quarter was a loss
of
$2.00​.
    * The mean earnings estimate of analysts had risen by
about 22.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Mustang Bio Inc shares had fallen by 35.1% this
quarter and
lost 32.0% so far this year.
    * The company reported a quarterly loss of $16.24 million.
    * Wall Street's median 12-month price target for Mustang Bio
Inc
is $19.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 15 at 07:10 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -1.81          -2.00          Missed
 Mar. 31 2023      -3.01          -2.06          Beat
 Dec. 31 2022      -2.89          -2.70          Beat
 Sep. 30 2022      -2.96          -2.70          Beat